Abstract
A β-d-glucan obtained from Aureobasidium pullulans (AP-FBG) exhibits various biological activities: it exhibits antitumour and antiosteoporotic effects and prevents food allergies. An unambiguous structural characterisation of AP-FBG is still awaited. The biological effects of β-d-glucan are known to depend on its primary structures, conformation, and molecular weight. Here, we elucidate the primary structure of AP-FBG by NMR spectroscopy, and evaluate its biological activities. Its structure was shown to comprise a mixture of a 1-3-β-d-glucan backbone with single 1-6-β-d-glucopyranosyl side-branching units every two residues (major structure) and a 1-3-β-d-glucan backbone with single 1-6-β-d-glucopyranosyl side-branching units every three residues (minor structure). Furthermore, this β-d-glucan exhibited immunostimulatory effects such as the accumulation of immune cells and priming effects against enterobacterium. To our knowledge, 1-3-β-glucans like AP-FBG with such a high number of 1-6-β-glucopyranosyl side branching have a unique structure; nevertheless, many 1-3-β-glucans were isolated from various sources, e.g. fungi, bacteria, and plants.
Similar content being viewed by others
Abbreviations
- AP-FBG:
-
Aureobasidium pullulans-fermented β-glucan
- BRM:
-
biological response modifier
- CR3:
-
complement receptor type 3
- COSY:
-
correlation spectroscopy
- CSBG:
-
β-glucan from Candida albicans
- DB:
-
degree of branching
- DP:
-
degree of polymerisation
- Enterococcus faecalis :
-
E. faecalis
- ELISA:
-
enzyme-linked immunosorbent assay
- FCS:
-
foetal calf serum
- HMBC:
-
heteronuclear multiple bond correlation spectroscopy
- HSQC:
-
heteronuclear single quantum correlation spectroscopy
- H2BC:
-
heteronuclear 2-bond correlation spectroscopy
- IFN:
-
interferon
- IL:
-
interleukin
- LacCer:
-
lactosylceramide
- NMR:
-
nuclear magnetic resonance
- NOESY:
-
nuclear Overhauser effect spectroscopy
- PAMPs:
-
pathogen associated molecular patterns
- PBMCs:
-
peripheral blood mononuclear cells
- PBS:
-
phosphate-buffered saline
- PBST:
-
0.05% Tween 20 containing PBS
- BPBST:
-
1% BSA containing PBST
- PECs:
-
peritoneal exudate cells
- PMN:
-
polymorphonuclear cell
- PRRs:
-
pattern recognition receptors
- ROE:
-
rotating-frame Overhauser effect
- SPG:
-
sonifilan
- TLRs:
-
toll-like receptors
- TNF:
-
tumour necrosis factor
- TOCSY:
-
total correlation spectroscopy
References
Yadomae, T.: Structure and biological activities of fungal beta-1,3-glucans. Yakugaku Zasshi 120, 413–431 (2000)
Yadomae, T., Ohno, N.: Structure-activity relationship of immunomodulating (1→3)-beta-d-glucans. Rec. Res. Dev. Chem. Pharm. Sci. 1, 23–33 (1996)
Kim, Y.T., Kim, E.H., Cheong, C., Williams, D.L., Kim, C.W., Lim, S.T.: Structural characterization of beta-D-(1 → 3, 1 → 6)-linked glucans using NMR spectroscopy. Carbohydr. Res. 328, 331–341 (2000)
Borchers, A.T., Keen, C.L., Gershwin, M.E.: Mushrooms, tumors, and immunity: an update. Exp. Biol. Med. (Maywood) 229, 393–406 (2004)
Hamano, K., Gohra, H., Katoh, T., Fujimura, Y., Zempo, N., Esato, K.: The preoperative administration of lentinan ameliorated the impairment of natural killer activity after cardiopulmonary bypass. Int. J. Immunopharmacol. 21, 531–540 (1999)
Kalra, S., Jood, S.: Effect of dietary barley beta-glucan on cholesterol and lipoprotein fractions in rats. J. Cereal Sci. 31, 141–145 (2000)
Taguchi, T., Furue, H., Kimura, T., Kondo, T., Hattori, T., Ogawa, N.: Clinical efficacy of lentinan on neoplastic diseases. Adv. Exp. Med. Biol. 166, 181–187 (1983)
Fujimoto, S., Orita, K., Kimura, T., Kondo, T., Taguchi, T., Yoshida, K., Ogawa, N., Furue, H.: Clinical evaluation of SPG (schizophyllan) as a therapeutic adjuvant after surgery of gastric cancer-controlled study by an envelope method. Gan To Kagaku Ryoho 10, 1135–1145 (1983)
Deshpande, M.S., Rale, V.B., Lynch, J.M.: Aureobasidium pullulans in applied microbiology: a status report. Enzyme Microb. Technol. 14, 514–527 (1992)
Yuen, S.: Pullulans and its applications. Process Biochem. 9, 7–9 (1974)
Kimura, Y., Sumiyoshi, M., Suzuki, T., Sakanaka, M.: Antitumor and antimetastatic activity of a novel water-soluble low molecular weight beta-1, 3-d-glucan (branch beta-1,6) isolated from Aureobasidium pullulans 1A1 strain black yeast. Anticancer Res. 26, 4131–4141 (2006)
Ikewaki, N., Fujii, N., Onaka, T., Ikewaki, S., Inoko, H.: Immunological actions of Sophy beta-glucan (beta-1,3-1,6 glucan), currently available commercially as a health food supplement. Microbiol. Immunol. 51, 861–873 (2007)
Kimura, Y., Sumiyoshi, M., Suzuki, T., Suzuki, T., Sakanaka, M.: Inhibitory effects of water-soluble low-molecular-weight beta-(1,3-1,6)-d-glucan purified from Aureobasidium pullulans GM-NH-1A1 strain on food allergic reactions in mice. Int. Immunopharmacol. 7, 963–972 (2007)
Shin, H.D., Yang, K.J., Park, B.R., Son, C.W., Jang, H.J., Ku, S.K.: Antiosteoporotic effect of Polycan, beta-glucan from Aureobasidium, in ovariectomized osteoporotic mice. Nutrition 23, 853–860 (2007)
Ross, G.D., Cain, J.A., Myones, B.L., Newman, S.L., Lachmann, P.J.: Specificity of membrane complement receptor type three (CR3) for beta-glucans. Complement 4, 61–74 (1987)
Zimmerman, J.W., Lindermuth, J., Fish, P.A., Palace, G.P., Stevenson, T.T., DeMong, D.E.: A novel carbohydrate-glycosphingolipid interaction between a beta-(1–3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes. J. Biol. Chem. 273, 22014–22020 (1998)
Brown, G.D., Gordon, S.: Immune recognition. A new receptor for beta-glucans. Nature 413, 36–37 (2001)
Saijo, S., Fujikado, N., Furuta, T., Chung, S.H., Kotaki, H., Seki, K., Sudo, K., Akira, S., Adachi, Y., Ohno, N., Kinjo, T., Nakamura, K., Kawakami, K., Iwakura, Y.: Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat. Immunol. 8, 39–46 (2007)
Adachi, Y., Ishii, T., Ikeda, Y., Hoshino, A., Tamura, H., Aketagawa, J., Tanaka, S., Ohno, N.: Characterization of beta-glucan recognition site on C-type lectin, dectin 1. Infect. Immun. 72, 4159–4171 (2004)
Ishibashi, K., Miura, N.N., Adachi, Y., Ohno, N., Yadomae, T.: Relationship between solubility of grifolan, a fungal 1,3-beta-D-glucan, and production of tumor necrosis factor by macrophages in vitro. Biosci. Biotechnol. Biochem. 65, 1993–2000 (2001)
Ohno, N., Uchiyama, M., Tsuzuki, A., Tokunaka, K., Miura, N.N., Adachi, Y., Aizawa, M.W., Tamura, H., Tanaka, S., Yadomae, T.: Solubilization of yeast cell-wall beta-(1→3)-d-glucan by sodium hypochlorite oxidation and dimethyl sulfoxide extraction. Carbohydr. Res. 316, 161–172 (1999)
Griesinger, C., Otting, G., Wuthrich, K., Ernst, R.R.: Clean TOCSY for proton spin system identification in macromolecules. J. Am. Chem. Soc. 110, 7870–7872 (1988)
Petersen, B.O., Vinogradov, E., Kay, W., Wurtz, P., Nyberg, N.T., Duus, J.O., Sorensen, O.W.: H2BC: a new technique for NMR analysis of complex carbohydrates. Carbohydr. Res. 341, 550–556 (2006)
Nyberg, N.T., Duus, J.O., Sorensen, O.W.: Editing of H2BC NMR spectra. Magn. Reson. Chem. 43, 971–974 (2005)
Nyberg, N.T., Duus, J.O., Sorensen, O.W.: Heteronuclear two-bond correlation: suppressing heteronuclear three-bond or higher NMR correlations while enhancing two-bond correlations even for vanishing 2JCH. J. Am. Chem. Soc. 127, 6154–6155 (2005)
Morikawa, K., Kikuchi, Y., Abe, M., Yamazaki, M., Mizuno, D.: Early cellular responses in the peritoneal cavity of mice to antitumor immunomodulators. Gann 75, 370–378 (1984)
Tada, R., Nagi-Miura, N., Adachi, Y., Ohno, N.: An unambiguous assignment and structural analysis using solution NMR experiments of O-antigen from Escherichia coli ATCC23505 (serotype O9). Chem. Pharm. Bull. 55, 992–995 (2007)
Masuzawa, S., Yoshida, M., Ishibashi, K., Saito, N., Akashi, M., Yoshikawa, N., Suzuki, T., Nameda, S., Nagi-Miura, N., Adachi, Y., Ohno, N.: Solubilized Candida cell wall β-glucan, CSBG, is an epitope of natural human antibody. Drug Dev. Res. 58, 179–189 (2003)
Harada, T., Nagi-Miura, N., Adachi, Y., Nakajima, M., Yadomae, T., Ohno, N.: Antibody to soluble 1,3/1,6-beta-d-glucan, SCG in sera of naïve DBA/2 mice. Biol. Pharm. Bull. 26, 1225–1228 (2003)
Ishibashi, K., Yoshida, M., Nakabayashi, I., Shinohara, H., Miura, N.N., Adachi, Y., Ohno, N.: Role of anti-beta-glucan antibody in host defense against fungi. FEMS Immunol. Med. Microbiol. 44, 99–109 (2005)
Kimura, Y., Sumiyoshi, M., Suzuki, T., Sakanaka, M.: Effects of water-soluble low-molecular-weight beta-1, 3-D-glucan (branch beta-1, 6) isolated from Aureobasidium pullulans 1A1 strain black yeast on restraint stress in mice. J. Pharm. Pharmacol. 59, 1137–1144 (2007)
Ohno, N., Suzuki, I., Yadomae, T.: Structure and antitumor activity of a beta-1,3-glucan isolated from the culture filtrate of Sclerotinia sclerotiorum IFO 9395. Chem. Pharm. Bull. 34, 1362–1365 (1986)
Saito, K., Nishijima, M., Ohno, N., Yadomae, T., Miyazaki, T.: Structure and antitumor activity of the less-branched derivatives of an alkali-soluble glucan isolated from Omphalia lapidescens. (Studies on fungal polysaccharide. XXXVIII). Chem. Pharm. Bull. 40, 261–263 (1992)
Acknowledgements
We would like to express our sincere appreciation to Misato Ebara for her consistent help and support. This work was supported by a grant for private universities provided by the Ministry of Education, Culture, Sports, Science, and Technology and Japan Private School Promotion Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tada, R., Tanioka, A., Iwasawa, H. et al. Structural characterisation and biological activities of a unique type β-d-glucan obtained from Aureobasidium pullulans . Glycoconj J 25, 851–861 (2008). https://doi.org/10.1007/s10719-008-9147-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10719-008-9147-3